MeOmics Technology

MeOmics Technology is a biotech firm specializing in mental health diagnosis and treatment improvement.

ActiveBioTechHealth CareHealth DiagnosticsMedical

Updated: Feb 17, 2026 ·

About

MeOmics Technology is a company dedicated to advancing personalized medical care, with a specific emphasis on mental health. As a university spin-out, the organization leverages academic research to develop its approach to precision medicine. Its work involves the application of pharmacogenomics, a field that examines how genes affect a person's response to drugs, to improve psychiatric treatments.

Recent News & Mentions

Feb 9, 2026FundingMeOmics Technology - Venture Round

Financial History

MeOmics Technology has raised $408K across 1 funding round. Most recently, it raised $408K Venture Round in February 2026.

Total Raised

$408K

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Feb 9, 2026	$408K Venture Round	Development Bank of Wales, Women Angels of Wales

Financial History

MeOmics Technology has raised $408K across 1 funding round.

Total Raised

$408K

Valuation

N/A

Deep Dive

The company operates within the pharmaceutical manufacturing industry, indicating its involvement in the development or production of medical solutions. This focus positions MeOmics Technology at the intersection of biotechnology and mental healthcare, aiming to tailor treatments to individual patient profiles.

Leadership at MeOmics Technology includes Alasdair Pettigrew, who holds the roles of Executive Chair and Acting CEO. His involvement underscores the company's commitment to strategic development and operational execution in its specialized field. Additionally, J.T.R.W. is noted as a shareholder in the company, further indicating key individual involvement.

MeOmics Technology is headquartered in Cardiff, United Kingdom. Its foundational structure as a university spin-out suggests a strong link to research and development, aiming to translate scientific discoveries into practical applications for patient care in mental health.

Sources

Frequently Asked Questions

What specific area of personalized medicine does MeOmics Technology focus on?

MeOmics Technology focuses on personalized medical care within the mental health sector, specifically utilizing pharmacogenomics for precision medicine in psychiatry.

Who are some key individuals associated with MeOmics Technology?

Alasdair Pettigrew serves as Executive Chair and Acting CEO, while J.T.R.W. is a shareholder in MeOmics Technology Ltd.